LIVE: While initial cues showed a higher open for India, a global tech and AI-related selloff in stocks the previous day and ...

Also in today’s newsletter, Vanke’s crisis reignite fears for China’s property sector, and Tesla sues EU over tariffs on EVs from China ...

Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...

HistoSonics develops a medical device that treats liver cancer by directing ultrasound energy precisely at tumor issue, an approach known as histotripsy, according to its website. The pulsing sound ...

R.F. Lafferty & Co., Inc. acted as the representative of the underwriters, with Revere Securities LLC acting as co-underwriter (collectively, the “Underwriters”) for the Offering. The Crone Law Group, ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

Loeb & Loeb, which launched a Beijing office in 2008, has been playing the long game and is now outgunning the likes of ...

Venture Global’s stock fell about 4% below its initial public offering price in its market debut on Friday, after the liquefied natural gas ...

Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise ...

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

EcoCeres Inc., a producer of sustainable fuel backed by Bain Capital, is exploring an initial public offering that could ...